How the Ebola scare stigmatized African immigrants in the US

November 02, 2015

The deadly Ebola virus outbreak in West Africa also took its toll socially on one of the fastest growing populations in the United States, African immigrants. Guy-Lucien Whembolua, a University of Cincinnati assistant professor of Africana studies, leads an analysis of national news coverage of the Ebola scare in a poster presentation on Nov. 2, at the 143rd American Public Health Association (APHA) Annual Meeting and Expo, in Chicago.

The examination reviewed reports in mainstream U.S. media related to African immigrants and the Ebola Virus Disease (EVD). The search turned up 21 news articles that matched the criteria for the study - articles focusing on African immigrants in the U.S. and the Ebola virus.

The researchers found that these African immigrants experienced stigma similar to communities stigmatized by the AIDS epidemic in the '80s. "There was strong discrimination against homosexual men during the AIDS epidemic and laying blame on that population for the spread of the virus," says Whembolua. "Similarly, in the early stages of the Ebola Virus outbreak in West Africa and amid sensationalized reports, we found a fear linked with African immigrants around spreading the disease in the U.S. Some of these populations felt they had to hide their ethnicity in an effort to avoid the stigma."

As a result, Whembolua says particularly in New York where there's a high Liberian immigrant population, there was a great deal of shame in being associated with Liberia. "Children were teased in high school, or adults were the butt of jokes at work. People from Nigeria also were stigmatized by the Ebola scare, resulting in stress and hardships for these populations," says Whembolua.

The researchers add that understanding this stigma faced by African communities in the U.S. could help improve health promotion programs targeting immigrants. They emphasize that the outbreak highlights a need for research on infectious disease that's relatively unknown in the U.S. and the Western world.

"There's more to the high death rate from the Ebola Virus in West Africa than just the virus itself," says Whembolua. "These countries don't have the infrastructures to combat the virus, and most of the populations affected already have low immune systems as the result of living in an impoverished country."

A Pew Research Center analysis of U.S. Census Bureau data, reported last spring, found that the black immigrant population in the U.S. is more than four times the number it was in 1980, and rapid growth is expected to continue.

Future UC research involving focus groups with populations stigmatized by the Ebola scare is currently under development in collaboration with Binghamton University.
Other researchers on the project include Donaldson Conserve, a postdoctoral research fellow at University of North Carolina at Chapel Hill; Daudet Ilunga Tshiswaka, a graduate student in the Department of Kinesiology and Community Health, University of Illinois-Champaign; Muswamba Mwamba, a graduate student in the Gillings School of Global Health, University of North Carolina, Chapel Hill; and Michael Gaisie, an undergraduate student in the UC School of Human Services in the College of Education, Criminal Justice, and Human Services.

Whembolua is program chair of the APHA's Caucus on Refugee and Immigrant Health and has served in that position since 2014. He is also director of UC's Africana Health Research Laboratory in the McMicken College of Arts and Sciences.

The American Public Health Association is the oldest and most diverse organization of public health professionals in the world and is dedicated to improving public health.

UC's Africana Studies Department in the McMicken College of Arts and Sciences is devoted to the academic study of the history, culture, health and politics of African, African-American, Afro-Latin, Afro-Caribbean and Afro-European populations.

University of Cincinnati

Related Ebola Virus Articles from Brightsurf:

Targeting the shell of the Ebola virus
As the world grapples with COVID-19, the Ebola virus is again raging.

New universal Ebola vaccine may fight all four virus species that infect humans
Infectious disease scientists report early development of a potential universal vaccine for Ebola viruses that preclinical tests show might neutralize all four species of these deadly viruses infecting people in recent outbreaks, mainly in Africa.

Researchers show how Ebola virus hijacks host lipids
Robert Stahelin studies some of the world's deadliest viruses. Filoviruses, including Ebola virus and Marburg virus, cause viral hemorrhagic fever with high fatality rates.

Recognise and control new variants of the deadly Ebola virus more quickly
Joint press release by the DZIF and Charité. The situation is extraordinary: there have only ever been four declarations of public health emergencies of international concern in the past and now there are two at the same time.

Investigational drugs reduce risk of death from Ebola virus disease
The investigational therapeutics mAb114 and REGN-EB3 offer patients a greater chance of surviving Ebola virus disease (EVD) compared to the investigational treatment ZMapp, according to published results from a clinical trial conducted in the Democratic Republic of the Congo (DRC).

Researchers learn how Ebola virus disables the body's immune defenses
A new study by researchers from The University of Texas Medical Branch at Galveston uncovered new information on why the Ebola virus can exert such catastrophic effects on the infected person.

Mutant live attenuated Ebola virus immunizes non-human primates
Inoculation with an Ebola virus that has mutations in a protein called VP35 does not cause disease and elicits protection in monkeys, researchers show Sept.

Groundbreaking study could lead to fast, simple test for Ebola virus
In a breakthrough that could lead to a simple and inexpensive test for Ebola virus disease, researchers have generated two antibodies to the deadly virus.

RIT professor develops microfluidic device to better detect Ebola virus
A faculty-researcher at Rochester Institute of technology has developed a prototype micro device with bio-sensors that can detect the deadly Ebola virus.

NEJM applying universal standards of care to Ebola virus disease
LSTM's Senior Clinical Lecturer, Dr. Shevin Jacob, is corresponding author on a perspective piece published in the New England Journal of Medicine calling for universal standards of care to be applied in relation to ebola virus disease.

Read More: Ebola Virus News and Ebola Virus Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to